PANCREATIC CANCER, ADVANCED OR METASTATIC
Clinical trials for PANCREATIC CANCER, ADVANCED OR METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER, ADVANCED OR METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER, ADVANCED OR METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough pancreatic cancers: testing targeted drug combos
Disease control Recruiting nowThis study is testing which of two different drug combinations works better for people with advanced pancreatic cancer that has specific genetic changes (BRCA1, BRCA2, or PALB2 mutations) and has stopped responding to their first treatment. It will compare a newer combination cal…
Matched conditions: PANCREATIC CANCER, ADVANCED OR METASTATIC
Phase: PHASE2, PHASE3 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New pill tested to fight tough cancers
Disease control Recruiting nowThis early-stage study is testing a new oral drug called CP-383 in people with advanced solid tumors that have spread or returned. The main goals are to find a safe dose and see if the drug can slow or stop cancer growth. It is for patients who have run out of standard treatment …
Matched conditions: PANCREATIC CANCER, ADVANCED OR METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC